What this Trial Is About

Researchers at the Urology Unit of AOUI Verona are conducting a study to evaluate postoperative complications in patients undergoing robotic partial nephrectomy (RAPN) for localized kidney tumors. The study focuses on comparing two robotic surgery platforms: the DaVinci Surgical System and the Hugo RAS System. It aims to investigate differences in intra- and postoperative complications, as well as oncological, functional, technical, and economic outcomes between these two approaches. Participants will be assigned to one of two groups based on the surgical platform used for their partial nephrectomy: either the DaVinci RAPN or the Hugo RAS RAPN. Both interventions involve robot-assisted surgery aimed at removing part of the kidney affected by cancer while preserving healthy tissue. The study does not specify further treatment or dosing details beyond these surgical procedures. During the study, researchers will monitor participants for postoperative complications over the first four days after surgery. They will record the number of patients experiencing any complications, moderate to major complications, and major complications specifically. Participants are expected to comply with scheduled follow-up assessments and consent to the monitoring program. The study focuses on measuring safety and surgical outcomes within this immediate postoperative period.

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)